Patent · US Active

JAK kinase inhibitor, preparation method for same, and applications thereof in field of medicine

US12398141B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignees

Inventors

Xin Xu · Dongying, CN
Jia Chen · Ningbo City, CN
Zhen Zhang · Shanghai, CN
Guan Wang · Shanghai, CN
Linli Zhang · Houston, US
Qiang Li · Beijing, CN
Chenghao Xi · Shanghai, CN
Minkai Qu · Shanghai, CN
Xiaojuan Zhang · Fuyang, CN
Chunqiao Chen · Shanghai, CN
Fan Yang · Brookline, US
Xiaoer XIA · Shanghai, CN
Yijin Wang · Dongguan, CN
Yunfei Li · Fremont, US
Jian Ge · Hubei, CN

Key dates

Filing date	Mar 11, 2020
Grant date	Aug 26, 2025
Priority date	—
Expiry date	Oct 13, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P17/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Related are a JAK kinase inhibitor, a preparation method for same, and applications thereof in the field of medicine, related to the field of medicinal chemistry. Provided is a novel small molecule JAK inhibitor, which has the structure as represented by formula (II). The compound provides improved efficacy and safeness in preventing or treating a JAK-related indication.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.